Skip to main content
. 2021 Mar 26;16(3):e0248603. doi: 10.1371/journal.pone.0248603

Fig 2. The Kaplan–Meier estimates of cumulative survival rate.

Fig 2

Patients with intermediate-high-risk pulmonary embolism were treated with either low-dose urokinase (UK) plus low-molecular-weight heparin (LMWH) or LMWH alone; p=0.894, based on the log-rank test.